Min, Kyungrok
Glowacki, Andrew J.
Bosma, Mary Lynn
McGuire, James A.
Tian, Sandy
McAdoo, Kathleen
DelSasso, Alicia
Fourre, Tara
Gambogi, Robert J.
Milleman, Jeffery
Milleman, Kimberly R.
Funding for this research was provided by:
Johnson & Johnson Consumer Inc
Article History
Received: 19 June 2023
Accepted: 13 May 2024
First Online: 18 May 2024
Declarations
:
: This trial was conducted in accordance with the International Council for Harmonization guidelines for Good Clinical Practice (E6 [R2]). The study protocol, informed consent document, and study materials were reviewed and approved by an independent institutional review board and ethics committee (IntegReview, LLC, Austin, TX). Written informed consent was obtained from all subjects. The CONSORT statement was followed for the reporting of this randomized clinical trial.
: Not applicable.
: This research was funded by Johnson & Johnson Consumer Inc. and conducted by its research team in partnership with Salus Research Inc. (Fort Wayne, IN), a third-party independent clinical research site qualified by the American Dental Association. Jeffrey Milleman and Kimberly Milleman are directors at Salus Research Inc. and declare no conflicts of interests with respect to the research, authorship, and/or publication of this article. The authors declare no conflict of interest or any direct involvement with study execution that would influence its outcome.